AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceuticals	143.53M	1.63M	1.44M
Pharmaceuticals Growth	8727.18%	13.31%	-
Total	143.53M	1.63M	1.44M
Total Growth	8727.18%	13.31%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Taiwan	587.00K	1.63M	1.44M
Taiwan Growth	-63.90%	13.31%	-
USA	142.94M	-	-
Total	143.53M	1.63M	1.44M
Total Growth	8727.18%	13.31%	-

Source: S&P Global Market Intelligence.